Analysed HALOZYME THERAPEUTICS INC (HALO:NASDAQ) News Sources
Did Halozyme’s Vertex Hypercon Licensing Deal Just Shift Halozyme Therapeutics’ (HALO) Investment Narrative?
10-04-2026
yahoo.com
Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology
07-04-2026
yahoo.com
How The Investment Story Is Shifting For Halozyme Therapeutics (HALO) After Recent Analyst Calls
04-04-2026
yahoo.com
What is the current price of HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The current price of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is $66.65.
HALOZYME THERAPEUTICS INC (HALO:NASDAQ) absolute price change since previous trading day?
The absolute price change of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) since the previous trading day is $-1.17.
HALOZYME THERAPEUTICS INC (HALO:NASDAQ) percentage price change since previous trading day?
The percentage price change of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) since the previous trading day is -1.7252%.
What is the most recent average sentiment score for HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The most recent average sentiment score for HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is 91 out of 100.
What is the most recent average sentiment for HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The most recent sentiment for HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is .
SEC-8K** Filing Available For HALOZYME THERAPEUTICS INC (HALO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.